SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-21-004926
Filing Date
2021-02-26
Accepted
2021-02-26 16:01:45
Documents
19
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 332834
2 ex4-11.htm EX-4.11 74592
3 ex10-33.htm EX-10.33 11581
4 ex31-1.htm EX-31.1 20442
5 ex31-2.htm EX-31.2 20692
6 ex32-1.htm EX-32.1 6857
7 ex32-2.htm EX-32.2 6850
8 ex10-33_001.jpg GRAPHIC 134415
9 ex10-33_002.jpg GRAPHIC 144665
10 ex10-33_003.jpg GRAPHIC 122126
11 ex10-33_004.jpg GRAPHIC 145649
12 ex10-33_005.jpg GRAPHIC 148813
13 ex10-33_006.jpg GRAPHIC 153968
14 ex10-33_007.jpg GRAPHIC 142242
15 ex10-33_008.jpg GRAPHIC 161643
16 ex10-33_009.jpg GRAPHIC 126204
17 ex10-33_010.jpg GRAPHIC 148396
18 ex10-33_011.jpg GRAPHIC 41726
19 ex10-33_012.jpg GRAPHIC 26824
  Complete submission text file 0001493152-21-004926.txt   2537446
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 001-36138 | Film No.: 21688558
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences